INDORIVA-18 is a brand of tiotropium bromide, a long‑acting anticholinergic (antimuscarinic) bronchodilator, used once daily to manage:

Chronic Obstructive Pulmonary Disease (COPD) — including chronic bronchitis and emphysema

Asthma — as maintenance therapy in patients 12 years and older, especially those with severe or frequent exacerbations

INDORIVA-18 is available in

Dry‑powder capsule— usually 18 µg per capsule; one capsule inhaled once daily.

The effect begins in about 30 minutes, becoming fully effective within 3 days to a week, and lasts about 24 hours .